Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-002638-35Phase 4Active
Phase 4, open-label, single-arm trial of albumin (human), sponsored by Region Stockholm. Primary endpoint: Transcapillary escape rate for albumin. Started Jun 2012; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-002638-35.